Does Rallies show ALNY 10-K and 10-Q filings?

Rallies organizes ALNY SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is ALNY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ALNY. It does not provide personalized investment advice.

ALNY (Alnylam Pharmaceuticals) Stock Analysis - SEC Filings

Alnylam Pharmaceuticals (ALNY) is a publicly traded Healthcare sector company. As of May 20, 2026, ALNY trades at $296.14 with a market cap of $38.22B and a P/E ratio of 122.46. ALNY moved +1.41% today. Year to date, ALNY is -26.46%; over the trailing twelve months it is +0.84%. Its 52-week range spans $205.87 to $495.55. Analyst consensus is strong buy with an average price target of $452.73. Rallies surfaces ALNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ALNY SEC filings?

Rallies organizes ALNY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ALNY Key Metrics

Key financial metrics for ALNY
Metric	Value
Price	$296.14
Market Cap	$38.22B
P/E Ratio	122.46
EPS	$2.39
Dividend Yield	0.00%
52-Week High	$495.55
52-Week Low	$205.87
Volume	603.28K
Avg Volume	0
Revenue (TTM)	$3.71B
Net Income	$313.75M
Gross Margin	81.77%

Latest ALNY News

Alnylam slips after Q1 results despite $1.04B product revenue and guidance reiteration — May 1, 2026
Alnylam jumps as Q1 profit and record $1.17B revenue top expectations — Apr 30, 2026
Alnylam slides as traders de-risk into April 30 Q1 results, valuation worries linger — Apr 24, 2026
Alnylam drops as Jefferies downgrade spotlights valuation after big run — Apr 19, 2026
Alnylam slides as valuation worries persist after Jefferies downgrade and target cut — Apr 18, 2026

Recent ALNY Insider Trades

McLaughlin Melissa sold 56 (~$17.93K) on Apr 6, 2026.
McLaughlin Melissa sold 909 (~$299.75K) on Apr 6, 2026.
McLaughlin Melissa sold 829 (~$273.95K) on Apr 6, 2026.

ALNY Analyst Consensus

18 analysts cover ALNY: 0 strong buy, 15 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $452.73.

Common questions about ALNY

Where can I find ALNY SEC filings?: Rallies organizes ALNY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ALNY 10-K and 10-Q filings?: Rallies organizes ALNY SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ALNY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ALNY. It does not provide personalized investment advice.